Financials

Income Statement Balance Sheet Cash Flow Ratios

Quarterly (SAR)

1-5

	Q1 2026Mar 31, 2026	Q4 2025Dec 31, 2025	Q3 2025Sep 30, 2025	Q2 2025Jun 30, 2025	Q1 2025Mar 31, 2025
Operating Summary
Revenue	481.38M	304.57M	342.31M	396.22M	457.53M
Cost of Revenue	171.00M	121.19M	133.77M	145.43M	164.68M
Gross Profit	310.38M	183.38M	208.54M	250.80M	292.85M
SG&A	125.39M	110.53M	90.86M	109.01M	122.15M
R&D	9.40M	10.86M	9.47M	8.98M	9.39M
Operating Expenses	138.01M	111.72M	98.61M	115.45M	134.66M
Operating Income	172.38M	71.66M	109.92M	135.35M	158.18M
Interest Income	2.32M	0.78M	0.99M	1.44M	1.81M
Interest Expense	-1.54M	—	-0.35M	-0.30M	-0.16M
Other Income/Expense	—	-1.17M	—	—	—
Pretax Income	174.94M	76.91M	113.34M	139.03M	163.81M
Income Tax	6.73M	8.84M	6.67M	7.01M	6.77M
Net Income	168.21M	68.07M	106.67M	132.02M	157.03M
EBITDA	183.73M	82.25M	120.95M	145.62M	168.29M
EBIT	172.38M	71.66M	109.92M	135.35M	158.18M
EPS (Basic)	2.40	0.97	1.52	1.89	2.24
EPS (Diluted)	2.40	0.97	1.52	1.89	2.24
Margins & Efficiency
Gross Margin %	+64.5%	+60.2%	+60.9%	+63.3%	+64.0%
EBITDA Margin %	+38.2%	+27.0%	+35.3%	+36.8%	+36.8%
Net Margin %	+34.9%	+22.4%	+31.2%	+33.3%	+34.3%
Revenue & Income
Revenue	481.38M	304.57M	342.31M	396.22M	457.53M
Revenue Growth (YoY)	+5.2%	+17.3%	+4.5%	+14.6%	+18.7%
Interest & Investment Income	2.32M	0.78M	0.99M	1.44M	1.81M
Earnings From Equity Investments	1.78M	4.54M	2.78M	2.55M	3.97M
Gain (Loss) on Sale of Assets	—	—	—	—	—
Gain (Loss) on Sale of Investments	—	-0.10M	—	—	—
Currency Exchange Gain (Loss)	—	1.19M	—	—	—
Expenses & Provisions
Cost of Revenue	171.00M	121.19M	133.77M	145.43M	164.68M
Selling, General & Admin	125.39M	110.53M	90.86M	109.01M	122.15M
Research & Development	9.40M	10.86M	9.47M	8.98M	9.39M
Operating Expenses	138.01M	111.72M	98.61M	115.45M	134.66M
Other Operating Expenses	3.22M	-8.56M	-1.72M	-2.54M	3.13M
Interest Expense	-1.54M	—	-0.35M	-0.30M	-0.16M
Other Non Operating Income (Expenses)	—	-1.17M	—	—	—
Asset Writedown	—	—	—	—	—
D&A For EBITDA	11.35M	10.59M	11.02M	10.27M	10.11M
Profitability & Returns
Gross Profit	310.38M	183.38M	208.54M	250.80M	292.85M
Gross Margin	+64.5%	+60.2%	+60.9%	+63.3%	+64.0%
EBIT	172.38M	71.66M	109.92M	135.35M	158.18M
EBIT Margin	+35.8%	+23.5%	+32.1%	+34.2%	+34.6%
EBITDA	183.73M	82.25M	120.95M	145.62M	168.29M
EBITDA Margin	+38.2%	+27.0%	+35.3%	+36.8%	+36.8%
EBT Excluding Unusual Items	174.94M	77.01M	113.34M	139.03M	163.81M
Pretax Income	174.94M	76.91M	113.34M	139.03M	163.81M
Operating Income	172.38M	71.66M	109.92M	135.35M	158.18M
Operating Margin	+35.8%	+23.5%	+32.1%	+34.2%	+34.6%
Profit Margin	+34.9%	+22.4%	+31.2%	+33.3%	+34.3%
Net Income	168.21M	68.07M	106.67M	132.02M	157.03M
Net Income to Common	168.21M	68.07M	106.67M	132.02M	157.03M
Net Income Growth	+7.1%	+31.9%	+12.3%	+23.4%	+52.5%
Income Tax Expense	6.73M	8.84M	6.67M	7.01M	6.77M
Effective Tax Rate	+3.8%	+11.5%	+5.9%	+5.0%	+4.1%
Per Share & Capital
EPS (Basic)	2.40	0.97	1.52	1.89	2.24
EPS (Diluted)	2.40	0.97	1.52	1.89	2.24
EPS Growth	+7.1%	+31.9%	+12.3%	+23.5%	+52.5%
Dividend Per Share	—	2.00	—	2.00	—
Shares Change (YoY)	—	—	—	-0	—
Shares Outstanding (Basic)	70.00M	70.00M	70.00M	69.85M	70.00M
Shares Outstanding (Diluted)	70.00M	70.00M	70.00M	69.85M	70.00M
Dividend Growth	—	+37.0%	—	+25.0%	—
Free Cash Flow	-4.22M	184.83M	127.12M	55.45M	-14.14M
Free Cash Flow Margin	-0.9%	+60.7%	+37.1%	+14.0%	-3.1%
Free Cash Flow Per Share	-0.06	2.64	1.82	0.79	-0.20
Payout Ratio	+83.2%	—	+131.2%	—	+65.1%

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Quarterly (SAR)

1-5

	Q1 2026Mar 31, 2026	Q4 2025Dec 31, 2025	Q3 2025Sep 30, 2025	Q2 2025Jun 30, 2025	Q1 2025Mar 31, 2025
Operating Summary
Revenue	481.38M	304.57M	342.31M	396.22M	457.53M
Cost of Revenue	171.00M	121.19M	133.77M	145.43M	164.68M
Gross Profit	310.38M	183.38M	208.54M	250.80M	292.85M
SG&A	125.39M	110.53M	90.86M	109.01M	122.15M
R&D	9.40M	10.86M	9.47M	8.98M	9.39M
Operating Expenses	138.01M	111.72M	98.61M	115.45M	134.66M
Operating Income	172.38M	71.66M	109.92M	135.35M	158.18M
Interest Income	2.32M	0.78M	0.99M	1.44M	1.81M
Interest Expense	-1.54M	—	-0.35M	-0.30M	-0.16M
Other Income/Expense	—	-1.17M	—	—	—
Pretax Income	174.94M	76.91M	113.34M	139.03M	163.81M
Income Tax	6.73M	8.84M	6.67M	7.01M	6.77M
Net Income	168.21M	68.07M	106.67M	132.02M	157.03M
EBITDA	183.73M	82.25M	120.95M	145.62M	168.29M
EBIT	172.38M	71.66M	109.92M	135.35M	158.18M
EPS (Basic)	2.40	0.97	1.52	1.89	2.24
EPS (Diluted)	2.40	0.97	1.52	1.89	2.24
Margins & Efficiency
Gross Margin %	+64.5%	+60.2%	+60.9%	+63.3%	+64.0%
EBITDA Margin %	+38.2%	+27.0%	+35.3%	+36.8%	+36.8%
Net Margin %	+34.9%	+22.4%	+31.2%	+33.3%	+34.3%
Revenue & Income
Revenue	481.38M	304.57M	342.31M	396.22M	457.53M
Revenue Growth (YoY)	+5.2%	+17.3%	+4.5%	+14.6%	+18.7%
Interest & Investment Income	2.32M	0.78M	0.99M	1.44M	1.81M
Earnings From Equity Investments	1.78M	4.54M	2.78M	2.55M	3.97M
Gain (Loss) on Sale of Assets	—	—	—	—	—
Gain (Loss) on Sale of Investments	—	-0.10M	—	—	—
Currency Exchange Gain (Loss)	—	1.19M	—	—	—
Expenses & Provisions
Cost of Revenue	171.00M	121.19M	133.77M	145.43M	164.68M
Selling, General & Admin	125.39M	110.53M	90.86M	109.01M	122.15M
Research & Development	9.40M	10.86M	9.47M	8.98M	9.39M
Operating Expenses	138.01M	111.72M	98.61M	115.45M	134.66M
Other Operating Expenses	3.22M	-8.56M	-1.72M	-2.54M	3.13M
Interest Expense	-1.54M	—	-0.35M	-0.30M	-0.16M
Other Non Operating Income (Expenses)	—	-1.17M	—	—	—
Asset Writedown	—	—	—	—	—
D&A For EBITDA	11.35M	10.59M	11.02M	10.27M	10.11M
Profitability & Returns
Gross Profit	310.38M	183.38M	208.54M	250.80M	292.85M
Gross Margin	+64.5%	+60.2%	+60.9%	+63.3%	+64.0%
EBIT	172.38M	71.66M	109.92M	135.35M	158.18M
EBIT Margin	+35.8%	+23.5%	+32.1%	+34.2%	+34.6%
EBITDA	183.73M	82.25M	120.95M	145.62M	168.29M
EBITDA Margin	+38.2%	+27.0%	+35.3%	+36.8%	+36.8%
EBT Excluding Unusual Items	174.94M	77.01M	113.34M	139.03M	163.81M
Pretax Income	174.94M	76.91M	113.34M	139.03M	163.81M
Operating Income	172.38M	71.66M	109.92M	135.35M	158.18M
Operating Margin	+35.8%	+23.5%	+32.1%	+34.2%	+34.6%
Profit Margin	+34.9%	+22.4%	+31.2%	+33.3%	+34.3%
Net Income	168.21M	68.07M	106.67M	132.02M	157.03M
Net Income to Common	168.21M	68.07M	106.67M	132.02M	157.03M
Net Income Growth	+7.1%	+31.9%	+12.3%	+23.4%	+52.5%
Income Tax Expense	6.73M	8.84M	6.67M	7.01M	6.77M
Effective Tax Rate	+3.8%	+11.5%	+5.9%	+5.0%	+4.1%
Per Share & Capital
EPS (Basic)	2.40	0.97	1.52	1.89	2.24
EPS (Diluted)	2.40	0.97	1.52	1.89	2.24
EPS Growth	+7.1%	+31.9%	+12.3%	+23.5%	+52.5%
Dividend Per Share	—	2.00	—	2.00	—
Shares Change (YoY)	—	—	—	-0	—
Shares Outstanding (Basic)	70.00M	70.00M	70.00M	69.85M	70.00M
Shares Outstanding (Diluted)	70.00M	70.00M	70.00M	69.85M	70.00M
Dividend Growth	—	+37.0%	—	+25.0%	—
Free Cash Flow	-4.22M	184.83M	127.12M	55.45M	-14.14M
Free Cash Flow Margin	-0.9%	+60.7%	+37.1%	+14.0%	-3.1%
Free Cash Flow Per Share	-0.06	2.64	1.82	0.79	-0.20
Payout Ratio	+83.2%	—	+131.2%	—	+65.1%

Financials

Quarterly (SAR)

JAMJOOM PHARMA

Quarterly (SAR)